Valuation: BrainsWay Ltd.

Market Cap 605M 0 518M 485M 444M 833M 57.9B 844M 5.73B 2.23B 29.08B 2.27B 2.22B 96.2B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 605M 0 518M 485M 444M 833M 57.9B 844M 5.73B 2.23B 29.08B 2.27B 2.22B 96.2B EV / Sales 2026 *
8.8x
EV / Sales 2027 * 7.2x
Free-Float
90.36%
Yield 2026 *
-
Yield 2027 * -
1 day-0.99%
1 week-7.41%
Current month-7.88%
1 month-10.21%
3 months+2.45%
6 months+17.35%
Current year+44.38%
1 week 4,420
Extreme 4420
4,849
1 month 4,380
Extreme 4380
5,075
Current year 3,080
Extreme 3080
5,165
1 year 2,391
Extreme 2391
5,165
3 years 579.7
Extreme 579.7
5,165
5 years 272
Extreme 272
5,165
10 years 272
Extreme 272
5,165
Manager TitleAgeSince
Chief Executive Officer 54 2023-02-12
Chief Tech/Sci/R&D Officer 56 2006-04-30
Director of Finance/CFO 50 2023-05-22
Director TitleAgeSince
Chairman 74 2002-12-31
Director/Board Member 70 2006-10-31
Director/Board Member 56 2019-06-16
Date Insider Type Main position Quantity % Market Cap.
3/18/26 Other

Director

37,500 0.0956%
3/18/26 Other

Chief Technology Officer

63,881 0.1629%
Change 5-day change 1-year change 3-year change Capi.($)
-0.99%-7.41%+77.64%+651.50% 605M
+0.27%+6.97%+30.08%+18.23% 233B
+1.36%+8.10%+7.33%-12.52% 154B
+1.16%-3.98%-19.38%+32.14% 134B
+2.03%-2.82%-52.12%-0.10% 73B
-0.04%-1.98%+10.63%+17.63% 51.75B
+0.98%+2.26%-15.88%-11.61% 52.24B
+1.73%+7.05%+35.72%+33.77% 44.91B
+1.49%-0.36%+41.41%+53.72% 40.35B
+1.03%+1.53%+2.28%+8.48% 33.8B
Average +0.94%+0.84%+11.77%+79.12% 81.7B
Weighted average by Cap. +1.01%+2.99%+5.93%+13.81%

Financials

2026 *2027 *
Net sales 68.73M 0 58.87M 55.09M 50.43M 94.63M 6.58B 95.88M 651M 254M 3.3B 258M 252M 10.93B 84.08M 0 72.02M 67.39M 61.68M 116M 8.04B 117M 796M 310M 4.04B 316M 309M 13.37B
Net income 10.9M 0 9.34M 8.74M 8M 15.01M 1.04B 15.21M 103M 40.25M 524M 40.93M 40.04M 1.73B 20.11M 0 17.23M 16.12M 14.76M 27.69M 1.92B 28.06M 190M 74.27M 967M 75.52M 73.88M 3.2B
Net Debt - -
Logo BrainsWay Ltd.
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Employees
129
Date Price Change Volume
26-08-21 ILA 4,512.00 -0.99% 21,087
26-08-20 ILA 4,557.00 +1.38% 62,044
26-08-19 ILA 4,495.00 +1.08% 40,142
26-08-18 ILA 4,447.00 -3.18% 91,036
26-08-17 ILA 4,593.00 -5.75% 43,176

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BWAY Stock